GlassScriptPhysician profile
Abbasali Badami
NPI 1841641438
$17,885.20
in general payments reported to CMS, 2019-2025
10 companies · $1,412 in 2025
The $1,412 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $9,681 · 2024: $6,792 · 2025: $1,412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Travel and Lodging: $5,455 · Food and Beverage: $2,172 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,250.00 |
| Travel and Lodging | $5,454.52 |
| Food and Beverage | $2,171.94 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,695.81 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $1,370.47 | 2024 | Gore Bio-A Tissue Reinforcement, Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Boston Scientific Corporation | $1,367.14 | 2024-2025 | Spyglass Discover |
| Zimmer Biomet Holdings, INC. | $169.06 | 2024-2025 | Ribfix Blu Advantage, Ribfix Titan, Sternalock |
| Atricure, INC. | $86.24 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Davol INC. | $75.22 | 2023 | Phasix Mesh |
| Tela Bio, INC. | $42.43 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $33.72 | 2023 | Avycaz, Dalvance |
| Kci USA, INC. | $23.86 | 2023 | Activ.A.C. |
| Reprise Biomedical, INC. | $21.25 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abbasali Badami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.